Godavari Drugs Limited (BOM:530317)

Godavari Drugs Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Operating Activities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Net Income	40.89	43.8	55.49	37.86	52.45
Depreciation & Amortization	24.32	24.48	24.48	19.44	16.96
Other Operating Activities	29.58	38.45	42.01	31.94	25.73
Change in Accounts Receivable	-12.58	171	-14.88	-23.56	-104.58
Change in Inventory	-181.23	-72.91	-7.95	-98.22	46.16
Change in Other Net Operating Assets	106.35	-92.85	85	164.72	75.57
Operating Cash Flow	7.34	111.96	184.14	132.17	112.3
Operating Cash Flow Growth	-93.45%	-39.20%	39.32%	17.70%	745.75%

Investing Activities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Capital Expenditures	-267.23	-199.98	-132.01	-93.36	-52.45
Sale of Property, Plant & Equipment	-	-	1.88	1.48	-
Other Investing Activities	7.75	4.86	-2.08	5.49	2.74
Investing Cash Flow	-259.48	-195.12	-132.22	-86.39	-49.71

Financing Activities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Long-Term Debt Issued	130.76	127.28	-	1.65	-
Total Debt Issued	130.76	127.28	-	1.65	-
Long-Term Debt Repaid	-	-	-7.8	-	-27.08
Net Debt Issued (Repaid)	130.76	127.28	-7.8	1.65	-27.08
Issuance of Common Stock	231.13	-	-	-	-
Other Financing Activities	11.62	-46.61	-48.74	-39.36	-29.13
Financing Cash Flow	373.5	80.67	-56.54	-37.7	-56.21

Net Cash Flow

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Net Cash Flow	121.36	-2.5	-4.62	8.08	6.38

Free Cash Flow

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Free Cash Flow	-259.9	-88.02	52.12	38.81	59.85
Free Cash Flow Growth	-	-	34.30%	-35.15%	-
Free Cash Flow Margin	-24.38%	-7.71%	3.31%	2.43%	3.71%
Free Cash Flow Per Share	-34.07	-11.70	6.92	5.16	7.95
Levered Free Cash Flow	-291.29	-72.71	-12.12	-336.51	67.61
Unlevered Free Cash Flow	-266.41	-43.14	18.6	-311.97	85.42

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash Interest Paid	39.8	47.32	49.15	39.27	28.49
Cash Income Tax Paid	11.9	11.55	10.17	12.27	12.27
Change in Working Capital	-87.46	5.24	62.17	42.94	17.15

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 17, 2026

Data Sources Report a data error